Breast cancer diagnosed after age 70 years in Israeli BRCA1/BRCA2 pathogenic sequence variant carriers: a single institution experience
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Breast cancer diagnosed after age 70 years in Israeli BRCA1/BRCA2 pathogenic sequence variant carriers: a single institution experience ; day:21 ; month:2 ; year:2024 ; pages:1-5
Breast cancer research and treatment ; (21.2.2024), 1-5
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Bufman, Hila
Faermann, Renata
Halshtok-Neiman, Osnat
Shalmon, Anat
Gotlieb, Michael
Samoocha, David
Yagil, Yael
Feldman, Dana Madorsky
Friedman, Eitan
Sklair-Levy, Miri
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10549-023-07234-1
- URN
-
urn:nbn:de:101:1-2404291315020.559171256789
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bufman, Hila
- Faermann, Renata
- Halshtok-Neiman, Osnat
- Shalmon, Anat
- Gotlieb, Michael
- Samoocha, David
- Yagil, Yael
- Feldman, Dana Madorsky
- Friedman, Eitan
- Sklair-Levy, Miri
- SpringerLink (Online service)
Ähnliche Objekte (12)
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
Hereditäres Mammakarzinom: BRCA1, BRCA2 und BRCA3
Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers
Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series
A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium
COVID-19 vaccination uptake and safety profile among germline BRCA1 and BRCA2 pathogenic variant carriers in Singapore
Diagnostic mRNA splicing assay for variants in BRCA1 and BRCA2 identified two novel pathogenic splicing aberrations
Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years
Funktionelle Analyse unklassifizierter Varianten der Gene BRCA1 und BRCA2
BRCA1- und BRCA2-Mutationsträger : eine vergleichende Untersuchung beider Gruppen
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
Hereditäres Mammakarzinom: BRCA1, BRCA2 und BRCA3
Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers
Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series
A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium
COVID-19 vaccination uptake and safety profile among germline BRCA1 and BRCA2 pathogenic variant carriers in Singapore
Diagnostic mRNA splicing assay for variants in BRCA1 and BRCA2 identified two novel pathogenic splicing aberrations
Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years
Funktionelle Analyse unklassifizierter Varianten der Gene BRCA1 und BRCA2
BRCA1- und BRCA2-Mutationsträger : eine vergleichende Untersuchung beider Gruppen
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
Hereditäres Mammakarzinom: BRCA1, BRCA2 und BRCA3
Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers
Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series
A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium
COVID-19 vaccination uptake and safety profile among germline BRCA1 and BRCA2 pathogenic variant carriers in Singapore
Diagnostic mRNA splicing assay for variants in BRCA1 and BRCA2 identified two novel pathogenic splicing aberrations
Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years
Funktionelle Analyse unklassifizierter Varianten der Gene BRCA1 und BRCA2